Authors:
KROLICK KA
THOMPSON PA
INFANTE AJ
ZODA TE
BRANDON KM
Citation: Ka. Krolick et al., STRATEGIES FOR THE INHIBITION OF T-CELL RESPONSES INVOLVED IN MURINE EXPERIMENTAL MYASTHENIA-GRAVIS USING V-BETA-SPECIFIC IMMUNOTOXINS AND AN ANTIBODY SPECIFIC FOR CD40 LIGAND (ANTI-GP39), Journal of cellular biochemistry, 1995, pp. 146-146
Citation: Te. Zoda et al., NEONATAL TOLERANCE TO AN IMMUNODOMINANT T-CELL REACTIVITY DOES NOT CONFER RESISTANCE TO EAMG INDUCTION IN LEWIS RATS, Journal of neuroimmunology, 57(1-2), 1995, pp. 35-44
Citation: Ka. Krolick et al., EXAMINATION OF CHARACTERISTICS THAT MAY DISTINGUISH DISEASE-CAUSING FROM BENIGN ACHR-REACTIVE ANTIBODIES IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, Advances in neuroimmunology, 4(4), 1994, pp. 475-493
Citation: Te. Zoda et Ka. Krolick, T-CELL REPERTOIRE IN DETERMINING RESPONSIVENESS TO AN EPITOPE IMPORTANT IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS, The Journal of immunology, 150(8), 1993, pp. 79-79